The University of Texas MD Anderson Cancer Center
In research, The University of Texas MD Anderson Cancer Center stands highest in Pulmonary and Respiratory Medicine (#1 of 1,144 worldwide), Medicine (#13 of 10,443 worldwide) and Oncology (#1 of 772 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology, Genetics and Oncology — Hematology is 18.1× its share of world research.
- World rank, 2022–2025
- #137 of 28,054 · #197 all time
- Rank in United States
- #41 of 4,192
- Research works
- 75k ◆ 0% vs 2013–17
- Citations
- 3M 39.6 per fractional work
- Top-10% rate
- 17.8% record average 16.5%
- Open access
- 35% world 28%
What is The University of Texas MD Anderson Cancer Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Pulmonary and Respiratory MedicineSubfield | #1 of 1,144 | 16.4% | 945 | #4 | |
| MedicineField | #13 of 10,443 | 17.2% | 7,445 | #18 | |
| OncologySubfield | #1 of 772 | 18.0% | 1,628 | #3 | |
| Health SciencesDomain | #17 of 11,982 | 17.3% | 7,665 | #27 | |
| Life SciencesDomain | #34 of 7,800 | 18.9% | 2,465 | #59 | |
| HematologySubfield | #1 of 117 | 19.3% | 605 | #1 | |
| GeneticsSubfield | #1 of 98 | 15.6% | 409 | #2 | |
| Pathology and Forensic MedicineSubfield | #3 of 268 | 15.9% | 331 | #8 | |
| Immunology and MicrobiologyField | #8 of 682 | 20.7% | 432 | #27 | |
| Biochemistry, Genetics and Molecular BiologyField | #51 of 3,579 | 18.2% | 1,843 | #72 |
Each strip is that field’s whole ranked pool, with the notch where The University of Texas MD Anderson Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Pulmonary and Respiratory Medicine#4 #1
- Medicine#18 #13
- Oncology#3 #1
- Health Sciences#27 #17
- Life Sciences#59 #34
- Hematology#1 #1
- Genetics#2 #1
- Pathology and Forensic Medicine#8 #3
- Immunology and Microbiology#27 #8
- Biochemistry, Genetics and Molecular Biology#72 #51
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does The University of Texas MD Anderson Cancer Center specialise in?
Where its research is concentrated relative to its size: Hematology takes 18.1× the share of its output that it takes of world research.
- HematologySubfield · 605.4 works18×
- GeneticsSubfield · 408.7 works14×
- OncologySubfield · 1,627.8 works13×
- Cancer ResearchSubfield · 461.8 works9.7×
- OtorhinolaryngologySubfield · 73.3 works6.7×
- RadiationSubfield · 90.3 works6.0×
- Pathology and Forensic MedicineSubfield · 330.9 works5.8×
- Pulmonary and Respiratory MedicineSubfield · 944.7 works5.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.9×. Every wedge is a field page.
- Immunology and Microbiology 3.9×
- Medicine 3.5×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Neuroscience 0.8×
- Health Professions 0.6×
- Economics, Econometrics and Finance 0.6×
- Mathematics 0.6×
- Veterinary 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Physics and Astronomy 0.4×
- Dentistry 0.4×
- Nursing 0.3×
- Psychology 0.3×
- Decision Sciences 0.2×
- Chemistry 0.2×
- Computer Science 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.1×
- Environmental Science 0.0×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
- Chemical Engineering 0.0×
Who are the top researchers at The University of Texas MD Anderson Cancer Center?
Ranked on the composite score, Bharat B. Aggarwal, Alexander J. Lazar and Linghua Wang lead among researchers whose main affiliation is The University of Texas MD Anderson Cancer Center.
- 1 Bharat B. Aggarwal United States · #202 worldwide 4.2k citations · 117 works
- 2 Alexander J. Lazar United States · #1,358 worldwide 2.3k citations · 196 works
- 3 Linghua Wang United States · #1,539 worldwide 1.9k citations · 109 works
- 4 John N. Weinstein United States · #1,699 worldwide 2.2k citations · 93 works
- 5 Anne S. Tsao United States · #1,747 worldwide 1.6k citations · 107 works
- 6 Dimitrios P. Kontoyiannis United States · #2,210 worldwide 1.4k citations · 103 works
- 7 María E. Suarez‐Almazor United States · #2,370 worldwide 1.5k citations · 81 works
- 8 Stanley R. Hamilton United States · #2,381 worldwide 1.4k citations · 122 works
- 9 Bita Esmaeli United States · #2,393 worldwide 1.5k citations · 82 works
- 10 Yiling Lu United States · #2,516 worldwide 1.8k citations · 82 works
Which keywords describe research at The University of Texas MD Anderson Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Immunotherapy, Chemotherapy, Tumor Microenvironment, Radiotherapy, Cancer, Clinical Practice Guidelines and Targeted Therapy.
- Somatic Mutations
- Molecular Characterization
- Mutation
- Chimeric Antigen Receptor
- Genomic Instability
- PD-1 and PD-L1
- PET Imaging
- Acute Myeloid Leukemia
- Precision Medicine
- Breast Cancer
- Survival Analysis
- Neoadjuvant Therapy
- Cancer Therapy
- Rituximab
- Clinical Trials
- Lymphoma
- Clinical Practice Guidelines
- Epidemiology
- Cancer
- Immunotherapy
- Prognostic Factors
- Chemotherapy
- Tumor Microenvironment
- Radiotherapy
- Targeted Therapy
- Quality of Life
- Cancer Immunotherapy
- Hematopoietic Stem Cells
- Gene Expression
- Tumor Regression
- Biomarkers
- Metastasis
- AML
- Genetic Mutations
- Immune Checkpoint Blockade
- Leukemia
- CAR T Cells
- Therapeutic Targets
- Molecular Profiling
- Cell-Free DNA
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors1,027▲ 21×14 topics
- Immunotherapy989▲ 13×19 topics
- Chemotherapy971▲ 13×25 topics
- Cancer645▲ 4.4×53 topics
- Tumor Microenvironment572▲ 12×8 topics
- Epidemiology570▲ 1.31×125 topics
- Radiotherapy541▲ 13×13 topics
- Clinical Practice Guidelines460▲ 7.7×14 topics
- Targeted Therapy435▲ 18×5 topics
- Lymphoma430▲ 24×4 topics
- Quality of Life406▲ 2.6×49 topics
- Clinical Trials398▲ 5.4×19 topics
- Cancer Immunotherapy368▲ 22×3 topics
- Rituximab354▲ 21×4 topics
- Hematopoietic Stem Cells354▲ 37×3 topics
- Cancer Therapy335▲ 5.3×19 topics
- Gene Expression329▲ 4.9×19 topics
- Neoadjuvant Therapy328▲ 13×5 topics
- Tumor Regression321▲ 27×2 topics
- Survival Analysis317▲ 11×7 topics
- Biomarkers314▲ 4.2×16 topics
- Breast Cancer299▲ 11×11 topics
- Metastasis298▲ 7.9×12 topics
- Precision Medicine297▲ 5.8×8 topics
- AML293▲ 54×1 topic
- Acute Myeloid Leukemia293▲ 54×1 topic
- Genetic Mutations282▲ 5.9×23 topics
- PET Imaging269▲ 14×5 topics
- Immune Checkpoint Blockade260▲ 21×1 topic
- PD-1 and PD-L1260▲ 21×1 topic
- Leukemia259▲ 28×2 topics
- Genomic Instability258▲ 21×3 topics
- CAR T Cells248▲ 31×1 topic
- Chimeric Antigen Receptor248▲ 31×1 topic
- Therapeutic Targets232▲ 14×8 topics
- Mutation226▲ 11×5 topics
- Molecular Profiling223▲ 21×3 topics
- Molecular Characterization222▲ 11×6 topics
- Cell-Free DNA205▲ 19×2 topics
- Somatic Mutations203▲ 22×2 topics
Which research topics does The University of Texas MD Anderson Cancer Center publish most on?
By volume in 2022–2025: Acute Myeloid Leukemia Research, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Myeloid Leukemia Research Hematology 293 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 260 works
- 3 CAR-T cell therapy research Oncology 248 works
- 4 Cancer Genomics and Diagnostics Cancer Research 202 works
- 5 Chronic Lymphocytic Leukemia Research Genetics 182 works
- 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 167 works
- 7 Chronic Myeloid Leukemia Treatments Hematology 159 works
- 8 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 124 works
- 9 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 120 works
- 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 119 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has The University of Texas MD Anderson Cancer Center's research output changed?
Output in 2018–2022 was 0% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Houston
- Baylor College of Medicine
- University of Houston
- Rice University
- The University of Texas Health Science Center at Houston
- Johnson Space Center
- Texas Children's Hospital
- Houston Methodist
- Saudi Aramco (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.